ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · H2 FY26

Zenith Drugs H2 FY26 Results: Net Profit ₹1.6 Cr, Up 14.3% YoY

Zenith Drugs Ltd reported revenue from operations of ₹93 Cr (+41.8% YoY) and net profit of ₹1.6 Cr (+14.3% YoY) for H2 FY26.

H2 FY26 at a glance · ₹ crore
MetricH2 FY26H1 FY26H2 FY25
Revenue from operations93.078.265.6
Other income3.21.91.7
Total income96.280.167.4
Profit before exceptional items & tax3.12.63.8
Exceptional items0.00.20.2
Profit before tax3.12.33.5
Net profit1.62.31.4
Operating margin3.2%2.9%5.2%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+14.30%
Net profit, quarter on quarter-30.40%
Revenue, year on year+41.80%
Source

NSE results filing, NSE: ZENITHDRUG. Figures extracted from the filing.

Read the filing ↗

Zenith Drugs Ltd: key numbers

Share price
₹39.40
Market cap
₹67.57 Cr
Revenue (annual)
₹171.2 Cr
Net profit (annual)
₹3.94 Cr
P/E (TTM)
17.1×Sector 43.8×
Promoter holding
69.98%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zenith Drugs Ltd

All →